share_log
Moomoo 24/7 ·  04/19 08:09

Biodexa Pharmaceuticals Says We Have The Resources To Deliver Two Sets Of Preclinical Data And Three Sets Of Clinical Data In 2024; Our Development Pipeline Now Includes Five Programs, Of Which Four Are At Clinical Stage; With Pipeline Stronger Than It Has Ever Been, We Are Enthusiastic About The Potential For Our Company In 2024 And Beyond

Biodexa Pharmicals表示,我們有足夠的資源在2024年提供兩組臨床前數據和三組臨床數據;我們的開發計劃現在包括五個項目,其中四個處於臨床階段;隨着管道比以往任何時候都更強大,我們對公司在2024年及以後的潛力充滿熱情

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論